SCHEMBL7429368

SCHEMBL7429368

COC(=O)C(=Cc1ccccc1)c1ccc(OC)c(OC)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 1/20 0.58
AKR1C3 P42330 1/20 0.57
KDM4E B2RXH2 2/20 0.53
HTT P42858 1/20 0.53
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA4 P22748 1/20 0.53
CA6 P23280 1/20 0.53
CA7 P43166 1/20 0.53
TPMT P51580 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 3/20 0.51
GAA P10253 2/20 0.51
ABCB1 P08183 1/20 0.51
MAPT P10636 1/20 0.51
HPGD P15428 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7814134 0.88 AKR1C3 (0.71) TNFRSF1AAKR1C3KDM4EHTTCA12
SCHEMBL7814136 0.88 AKR1C3 (0.71) TNFRSF1AAKR1C3KDM4EHTTCA12
SCHEMBL12507687 0.87 ABCG2 (0.59) TNFRSF1AAKR1C3KDM4EHTTMEN1
SCHEMBL28673604 0.87 PDE4A (0.53) TNFRSF1AAKR1C3KDM4EHTTCA12
SCHEMBL27948969 0.87 PDE4A (0.53) TNFRSF1AAKR1C3KDM4EHTTCA12
SCHEMBL30159756 0.87 ABCG2 (0.59) TNFRSF1AAKR1C3KDM4EHTTMEN1
SCHEMBL28095655 0.85 AKR1C3 (0.52) AKR1C3KDM4EMEN1KMT2AALDH1A1
SCHEMBL28095654 0.85 AKR1C3 (0.52) AKR1C3KDM4EMEN1KMT2AALDH1A1
SCHEMBL4007167 0.81 AKR1C1 (0.63) AKR1C3KDM4EHTTMEN1KMT2A
SCHEMBL4007174 0.81 AKR1C1 (0.63) AKR1C3KDM4EHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235793-A2 VLA-4 INTEGRIN ANTAGONISTS Novartis AG (CH) 2002-09-04 EP disclosed
WO-2001042192-A2 VLA-4 INTEGRIN ANTAGONISTS NOVARTIS AG (CH) 2001-06-14 WO disclosed